“…By contrast, in XLH patients, low iron levels are associated with further increases in circulating FGF23 fragments, but intact FGF23 concentrations and hypophosphataemia are not influenced by serum iron [44] . Interestingly, some forms of intravenous iron administered to iron-deficient subjects without ADHR may also cause transient elevations in intact FGF23, hypophosphataemia, and osteomalacia if administered repeatedly [45][46][47][48] . FGF23-mediated hypophosphataemia also occurs due to abnormal FGF23 production in TIO, fibrous dysplasia of bone (FD), and linear sebaceous naevus syndrome.…”